The United States will pay the pharmaceutical company Pfizer $ 1.95 billion to produce and deliver 100 million doses of the company’s COVID-19 vaccine candidate in case the drug is effective in human trials, the company said in a press release on Wednesday. Pfizer will administer the vaccine when the …
Read More »AstraZeneca Covid-19 Vaccine Data Doesn’t Impress Some Experts
AstraZeneca Plc fell from a record in New York trade after data for the company’s Covid-19 vaccine candidate, while promising, fueled concerns about whether it can match competitors. Bernstein analysts led by Ronny Gal said the vaccine, developed in association with the University of Oxford, showed initial positive data, but …
Read More »Oxford COVID-19 Vaccine Trial: Coronavirus Vaccine is Safe, Induces an Immune Response, Scientists Say
In research published in The Lancet, scientists said they found that their experimental COVID-19 vaccine produced a dual immune response in people ages 18 to 55. Oxford COVID-19 Vaccine Trial: The coronavirus vaccine created by the University of Oxford appears safe and has demonstrated a protective immune response in hundreds …
Read More »Vanderbilt Seeks 1K Volunteers for COVID-19 Vaccine Trial
NASHVILLE, Tenn. (WTVF) – Vanderbilt University Medical Center says it will begin recruiting 1,000 volunteers in late July for a late-stage study of an experimental COVID-19 vaccine. Vanderbilt says the Phase 3 randomized, placebo-controlled trial will be open to people over the age of 18. They will receive two injections …
Read More »First US-Tested COVID-19 Vaccine Prepared for Final Test – CBS Boston
WASHINGTON (AP) – The first COVID-19 vaccine tested in the US boosted people’s immune systems as scientists expected, the researchers reported Tuesday, as the vaccines are about to begin key final tests. . “No matter how this is cut, this is good news,” Dr. Anthony Fauci, the top infectious disease …
Read More »